Establishment and characterization of four human pancreatic carcinoma cell lines: Genetic alterations in the TGFBR2 gene but not in the MADH4 gene

Cell and Tissue Research

Volumn 308, Issue 2, 2002, Pages 205-214

  Ku, Ja Lok ^a   Yoon, Kyong Ah ^a   Kim, Woo Ho ^a   Jang, Jin ^a   Suh, Kyung Suk ^a   Kim, Sun Whe ^a   Park, Yong Hyun ^a   Park, Jae Gahb ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Cell line; Human; Microsatellite instability; Mutation; Pancreatic cancer; TGFBR2 gene

Indexed keywords

PROTEIN; PROTEIN MADH4; PROTEIN TGFB2; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; DNA; MICROSATELLITE DNA; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; DNA FINGERPRINTING; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE SEQUENCE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MISSENSE MUTATION; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; BASE MISPAIRING; BIOSYNTHESIS; CARCINOMA; CELL CULTURE; CELL LINE; DNA REPAIR; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PANCREAS TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

BASE PAIR MISMATCH; CARCINOMA; CELL LINE; CLONING, MOLECULAR; DNA FINGERPRINTING; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA, COMPLEMENTARY; DNA, NEOPLASM; GENES, P53; HUMAN; MICROSATELLITE REPEATS; PANCREATIC NEOPLASMS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; HUMANS;

BACTERIA (MICROORGANISMS); MYCOPLASMA;

EID: 0036015685     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-001-0510-y     Document Type: Article

References (45)

1. The somatic mutation frequency of transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability
2. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer
3. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations
4. Molecular diagnosis of pancreas carcinoma
5. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium
6. Cell culture methods for human lung cancer
7. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas
8. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells
9. Cancer of the pancreas. Fifty years of surgery
10. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
11. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma
12. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer
13. Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer
14. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma
15. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
16. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase
17. Mutation of p53 gene in hepatocellular-carcinoma cell lines with HBX DNA
18. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: Identification of a 1-cM region of common alleic loss
19. Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors
20. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA
21. Establishment and characterization of 12 uterine cervical carcinoma cell lines: Common sequence variation in the E7 gene of HPV-16 positive cell lines
22. Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines
23. A simple precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections
24. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds
25. MTS-1(CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines
26. Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers
27. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability
28. Association of p53 gene mutations with short survival in pancreatic adeno-carcinoma
29. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors
30. Deletion of the p16 and p15 genes in human bladder tumors
31. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
32. Characteristics of cell lines established from human colorectal carcinoma
33. Characterization of cell lines established from human hepatocellular carcinoma
34. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β
35. Cancer statistics
36. Advances in PCR-based detection of mycoplasmas contaminating cell cultures
37. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma
38. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma
39. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta
40. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction
41. p16(CDKN2) is a major deletion target at 9p21 in bladder cancer
42. Establishment of a new human extrahepatic bile duct carcinoma cell lines (OCUCh-LM1) and experimental liver metastatic model
43. Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC)
44. p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness